Zavaczki, Erzsébet <br/><br/>
Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques.  [electronic resource] 

 -  Oxidative medicine and cellular longevity  2020 
 - 3721383 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1942-0994 
<br/><br/><label>Standard No.: </label>10.1155/2020/3721383  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Resorption--pathology<br/>Calcinosis<br/>Carotid Arteries--drug effects<br/>Cell Differentiation--drug effects<br/>Down-Regulation--drug effects<br/>Gene Expression Regulation--drug effects<br/>Heme Oxygenase-1--metabolism<br/>Hemoglobins--pharmacology<br/>Hemorrhage--pathology<br/>Humans<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Models, Biological<br/>Osteoclasts--drug effects<br/>Osteogenesis--drug effects<br/>Oxidation-Reduction--drug effects<br/>Plaque, Atherosclerotic--genetics<br/>Protein Binding--drug effects<br/>RANK Ligand--genetics<br/>RAW 264.7 Cells<br/>Receptor Activator of Nuclear Factor-kappa B--metabolism<br/>Signal Transduction--drug effects